Neuropsychiatric Disorders and Treatment Market Size to Reach USD 211.8 Billion by 2032 Global neuropsychiatric disorders and treatment market is entering a critical phase of expansion as mental health emerges as a central priority for healthcare systems worldwide. Valued at USD 146.5 billion in 2024, the market is projected to grow from USD 153.9 billion in 2025 to USD 211.8 billion by 2032, registering a CAGR of 4.9% over the forecast period. This sustained growth reflects rising diagnosis rates, increasing awareness, and steady innovation across pharmacological and non-pharmacological treatment pathways addressing complex neurological and psychiatric conditions. As societies confront the clinical, economic, and social burden of mental health disorders, neuropsychiatric care is increasingly viewed as a long-term healthcare investment rather than episodic intervention. Access the market report https://www.24lifesciences.com/neuropsychiatric-disorders-and-treatment-market-9553